Gefitinib-induced acute generalized exanthematous pustulosis in two patients with advanced non-small-cell lung cancer [19]

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 1101-1102

  Shih, H C ^a   Hsiao, Y P ^a   Wu, M F ^a   Yang, J H ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GEFITINIB; PREDNISOLONE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADVANCED CANCER; AGED; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; DRUG INDUCED DISEASE; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LETTER; LUNG NON SMALL CELL CANCER; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PUSTULE; PUSTULOSIS; RASH; SKIN BIOPSY; TREATMENT RESPONSE;

EID: 33749864561     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07511.x     Document Type: Letter

References (8)

1. Hotta K, Matsuo K, Ueoka H et al. Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama lung cancer study group experience. Ann Oncol 2005; 16:1817-23.
2. Cohen MH, Williams GA, Sridhara R et al. United States Food and Drug Administration drug approval summary: gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res 2004; 10:1212-18.
3. Kris MG, Natale RB, Herbst RS et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer. JAMA 2003; 290:2149-58.
4. Segaert S, Cutsem V. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol 2005; 16:1425-33.
5. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-93.
6. Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 2003; 139:1181-83.
7. Schmid S, Kuechler PC, Britschgi M et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 2002; 161:2079-86.
8. Sidoroff A, Halevy S, Bavinck JAB et al. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 2001; 28:113-9.